Combining treatments to boost tumor response in lung cancer

Trofinetide is intended to treat Rett syndrome, a neurodevelopmental disorder. Credit: SewCreamStudio/Shutterstock. Acadia Pharmaceuticals has submitted a marketing authorisation application (MAA) to the European Medicines

STM-01 is aimed at treating severe cardiovascular diseases. Credit: Orawan Pattarawimonchai/Shutterstock. Cellipont Bioservices and Secretome Therapeutics are set to enter a collaboration in the manufacture

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it